Jake Bates made a 52-yard field goal as time expired, and the Detroit Lions overcame a career-high five interceptions by Jared Goff to rally for a 26-23 win over the Houston Texans ...

TB Alliance is honored to join today's High-Level Meeting hosted by the Indonesian Ministry of Health. Leaders and experts in tuberculosis (TB) have convened to discuss strategies, innovations, and ...

KT&G Corporation ("KT&G" or the "Company") (KRX:033780), announced the 'KT&G Corporate Value-up Plan' on the 7th, that includes their goal of achieving 15% ROE and returning KRW 3.7 trillion to ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

Texas A&M women’s basketball had its first convincing victory of the season on Sunday afternoon with an 86-38 victory over ...

Signal No. 4 has been raised over some Northern Luzon provinces as Nika intensified into a typhoon which may make landfall on Monday morning either in Isabela or Aurora.

South Korea’s Alteogen (Kosdaq: 196170) has signed an exclusive licensing agreement with Japanese pharmaceutical company ...

Plus, news about Disc Medicine, AlloVir, Kalaris, Travere Therapeutics and Trevena: Daiichi Sankyo, Alteogen to develop subcutaneous version of Enhertu: Daiichi will pay $20 million upfront to the ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

As global markets navigate a busy earnings season with mixed signals from economic data, major indices like the Nasdaq Composite and S&P MidCap 400 have experienced volatility, highlighting investor ...